Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Hout, Marie Claire Van; Collins, Claire; Delargy, Ide; Crowley, Des

doi:10.1007/s11469-016-9710-2

Cited by 7 publications

(14 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the 26 studies included, 13 were conducted in the United States (US),[22, 25–28, 30, 33, 37, 38, 40–43] four were conducted in Canada,[23, 32, 39, 45] three were conducted in Australia[34–36] and Israel,[21, 31, 46] two were conducted in Ireland,[29, 44] and one covered an international sample. [24] There were 18 studies that sampled medical practitioners,[21, 24–26, 28–32, 34, 36, 37, 40–42, 44–46] and three studies that sampled pharmacists. [33, 35, 39] An additional five studies included in this review were grouped according to the high proportion of nursing professionals sampled.…”

Section: Resultsmentioning

confidence: 99%

“…[40] In addition to the support and opposition of medicinal cannabis, three studies reported a high proportion of neutrality when participants were asked whether medicinal cannabis had any clinical utility. [24, 28, 44] Regardless of pre-conceived beliefs; however, the relative support for medicinal cannabis increased if all other treatment options were exhausted or if therapy was to be used in the palliative domain. [26, 28, 29, 36, 37, 40, 41]…”

Section: Resultsmentioning

confidence: 99%

“…Medical practitioners raised issues surrounding self-cultivation such as reproducibility and contamination, the potential for recreational misuse, the potential for diversion into illicit channels, the risk of drug-drug interactions, and driving under the influence of cannabis. [21, 24, 32, 36, 37, 42, 44, 45] Furthermore, medical practitioners were mindful of the potential risks associated with uncontrolled supply. [31, 37] Finally, concern for the health of individual patients was mostly focused around psychiatric adverse effects.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review

et al. 2019

View full text Add to dashboard Cite

Background The number of jurisdictions allowing access to medicinal cannabis has been steadily increasing since the state of California introduced legislation in 1996. Although there is a high degree of legislative heterogeneity across jurisdictions, the involvement of a health professional is common among all. This places health professionals at the forefront of therapy, yet no systematic review of literature has offered insight into the beliefs, knowledge, and concerns of health professionals regarding medicinal cannabis. Methods Using a predetermined study protocol, PubMed, EMBASE, PsycINFO, CINAHL, and Scopus databases were searched for studies indexed up to the 1 st August 2018. Pre-defined inclusion and exclusion criteria were applied uniformly. Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Risk of bias was assessed using CASP criteria (qualitative) and a modified domain-based risk assessment tool (quantitative). Results Of the 15,775 studies retrieved, 106 underwent full-text review and of these, 26 were included. The overall risk of bias was considered low across all included studies. The general impression was that health professionals supported the use of medicinal cannabis in practice; however, there was a unanimous lack of self-perceived knowledge surrounding all aspects of medicinal cannabis. Health professionals also voiced concern regarding direct patient harms and indirect societal harms. Conclusion This systematic review has offered a lens through which to view the existing literature surrounding the beliefs, knowledge, and concerns of health professionals regarding medicinal cannabis. These results are limited, however, by the implicit common-sense models of behaviour utilised by the included studies. Before strategies can be developed and implemented to change health professional behaviour, a more thorough understanding of the factors that underpin the delivery of medicinal cannabis is necessary.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Conventional medicine is often seen as the ideal, and physicians argue that medical cannabis fails to comply with the standards of biomedicine. (11,34) They point out the lack of scienti c evidence of safety and e cacy. (11,34) However, some physicians agree on the limited evidence, but argue that other aspects of health care are likewise unsupported by evidence.…”

Section: Attitudes Towards Prescriptionmentioning

confidence: 99%

“…(11,34) They point out the lack of scienti c evidence of safety and e cacy. (11,34) However, some physicians agree on the limited evidence, but argue that other aspects of health care are likewise unsupported by evidence. (11) When physicians consider treatment of pain and palliative care where all conventional methods have been tried, they give much less weight to the lack of evidence and potential harms and are more inclined to support the use of medical cannabis.…”

Section: Attitudes Towards Prescriptionmentioning

confidence: 99%

Physicians’ experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review

Rønne

Rosenbæk

Pedersen

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: An increasing number of countries legalise the use of medical cannabis or allow it for a narrow range of medical conditions in patients. Physicians, and often the patients’ general practitioner, play a major role in the implementation of this policy, but many of them perceive a lack of evidence-based knowledge and may not be confident with providing patients with medical cannabis. The objectives of this review are to synthesise findings about hospital physicians’ and GPs’ experiences, attitudes, and beliefs towards the use of medical cannabis with the purpose of identifying barriers and facilitators towards providing it to their patients.Methods: Peer-reviewed articles addressing hospital physicians’ and GPs’ experiences, attitudes, and beliefs towards the use of medical cannabis were searched systematically in PubMed, Scopus, EMBASE, and the Cochrane Library.Results: Twenty-one articles were included from five different countries in which the medical cannabis laws varied. The studied physicians experienced frequent inquiries about medical cannabis from their patients (49-95%), and between 10-95% of the physicians were willing to provide it to the patients, depending on setting, specialty and experience among the physicians. This review found that physicians experienced in prescribing medical cannabis were more convinced of its benefits and less worried about adverse effects than non-experienced physicians. However, physicians specialized in addiction treatment and certain relevant indication areas seemed more sceptical compared to physicians in general. Nevertheless, physicians generally experienced a lack of knowledge of clinical effects including both beneficial and adverse effects.Conclusion: This review indicates that hospital physicians and GPs’ in various specialties frequently experience patient demands for medical cannabis and to some degree show openness to using it, although there was a wide gap between studies in terms of willingness to provide. Hospital physicians and GPs’ experienced in prescribing are more convinced of effects and less worried of adverse effects. However, most physicians experience a lack of knowledge of beneficial effects, adverse effects and of how to advise patients, which may comprise barriers towards prescribing. More research, including larger studies with cohort designs and qualitative studies, is needed to further examine facilitators and barriers to physicians’ prescribing practices.

show abstract

Attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy

Edelstein

2022

Epilepsy & Behavior

View full text Add to dashboard Cite

Irish General Practitioner (GP) Perspectives Toward Decriminalisation, Legalisation and Cannabis for Therapeutic Purposes (CTP)

Cited by 7 publications

References 48 publications

Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review

Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis – A systematic review

Physicians’ experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review

Attitudes and beliefs of medicine and social work students about medical cannabis use for epilepsy

Contact Info

Product

Resources

About